Markets:

News

Articles published by VeriSIM Life

Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases

Today 14:51 EDT

From VeriSIM Life

Via Business Wire

VeriSIM Life Awarded U.S. Government Agreement to Advance New Approach Methodologies for Drug Development

September 28, 2026

From VeriSIM Life

Via Business Wire

VeriSIM Life Formalizes Research Collaboration with FDA/NCTR, Advancing the Next Generation of Mechanistic AI for Drug Development

June 25, 2026

From VeriSIM Life

Via Business Wire

VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTech Breakthrough

November 03, 2022

From VeriSIM Life

Via Business Wire

VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs

June 28, 2022

From VeriSIM Life

Via Business Wire

VeriSIM Life CEO Dr. Jo Varshney Shares Pioneering Approach to Business and Life with MSNBC Mika Brzezinski's Know Your Value Platform

May 27, 2022

From VeriSIM Life

Via Business Wire

VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

May 26, 2022

From VeriSIM Life

Via Business Wire

Tickers ASX:TTB

VeriSIM Life Announces Acquisition of Molomics Biotech

May 11, 2022

From VeriSIM Life

Via Business Wire

VeriSIM Life Awarded Federal Grant from National Institutes of Health for Substance Use Disorder Drug Discovery and Development

April 19, 2022

From VeriSIM Life

Via Business Wire

VeriSIM Life to Present at Biotech Showcase and Participate in BIO Partnering at JPM Week

January 07, 2022

From VeriSIM Life

Via Business Wire

VeriSIM Life Secures $15 Million Series A Funding

January 06, 2022

From VeriSIM Life

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.